Healthcare operations

South Korea’s regulatory agency retains conditional approval for Neuronata-R, a key development for its market access and future commercialization.

• This Info Team
• July 20, 2026

A new pilot program tests daily postpartum check-ins for first-time mothers at home, aiming to improve recovery and reduce risks after birth.

• Thorsten Meyer
• July 19, 2026

4DMT announced positive two-year data from its PRISM Phase 2b clinical trial in a broad wet AMD population, showing promising efficacy results.

• This Info Team
• July 19, 2026

Harmony Biosciences announced an executive change through an SEC 8-K filing, signaling leadership updates at the company.

• This Info Team
• July 16, 2026

New app offers real-time voice biofeedback for transgender individuals, speakers, and singers without in-person coaching. Pilot testing underway.

• Thorsten Meyer
• July 13, 2026

McKesson’s media mentions have increased significantly, with 27 mentions in recent coverage, indicating heightened global attention on the healthcare company.

• This Info Team
• July 9, 2026

TaiMed Biologics has received the TFDA drug license collection notice for Trogarz, moving closer to commercial launch in Taiwan.

• This Info Team
• July 8, 2026

A new digital health tool aims to identify early signs of perimenopause in women 40-58, with potential benefits for individuals and employers. Testing underway.

• Thorsten Meyer
• July 7, 2026

A new web app pilot aims to help families plan and manage long-term care costs for aging parents, targeting caregivers aged 40-59 in the U.S.

• Thorsten Meyer
• July 4, 2026

Small clinics are set to test an AI-powered compliance brief generator, aiming to streamline regulatory updates and operational efficiency.

• Thorsten Meyer
• July 2, 2026